Classification of vasculitis: Why, what, and when?

APLAR Journal of Rheumatology

Volumn 7, Issue 2, 2004, Pages 146-149

  Bacon, P A ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTROPHIL CYTOPLASMIC ANTIBODY;

BRAIN VASCULITIS; CLINICAL FEATURE; COGAN SYNDROME; CONFERENCE PAPER; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; GIANT CELL ARTERITIS; HUMAN; PRIORITY JOURNAL; VASCULITIS;

EID: 23444440499     PISSN: 02190494     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1479-8077.2004.00077.x     Document Type: Conference Paper

References (8)

1. Lightfoot RJ, Michel BA, Bloch DA, et al. (1990) The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheumatism 33, 1088-93.
2. Davson J, Ball J, Platt R (2003) The kidney in periarteritis nodosa. Q J Med 17, 175-202.
3. Savage CO, Winnearls C, Evans D, Rees A, Lockwood CM (2003) Microscopic polyarteritis: presentation, pathology, and prognosis. Q J Med 56, 467-83.
4. Jennette JC, Falk RJ, Andrassy K, et al. (2003) Nomenclature of systemic vasculitides. Proposal of an international concensus conference. Arthritis Rheumatism 37, 187-92.
5. Weyand CM, Goronzy JJ (2002) Pathogenic mechanisms in giant cell arteritis. Cleve Clin J Med 69, SII28-32.
6. Jennette JC, Falk RJ (1997) Small-vessel vasculitis. N Engl J Med 337, 1512-23.
7. Bacon PA, Luqmani R (2002) Assessment of disease, activity and damage. In: Ball E, Bridges SL (eds.) Vasculitis. Oxford University Press, Oxford, 246-54.
8. Carruthers DC, Bacon PA (2001) Combination therapy in autoimmunedisease: vasculitis. Springer Seminars in Immunopathology 23, 91-108.